Released on = November 3, 2006, 12:41 pm

Press Release Author = GTCbio

Industry = Biotech

Press Release Summary = An upcoming conference on Drug Delivery Technology will
bring together scientists to discuss research aimed at creating safe and
non-invasive treatments for cancer, diabetes, asthma, Alzheimer's, cardiovascular
disease and a host of other conditions.

Press Release Body = MONROVIA, CA - Being diagnosed with diabetes traditionally
leads to insulin routines of up 4 injections per day. And cancer detection can mean
enduring invasive treatments such as chemotherapy and radiation. But recent
advancements in drug delivery technologies are helping to treat these diseases
without destroying the patient\'s quality of life.

An upcoming conference on Drug Delivery Technology will bring together scientists to
discuss research aimed at creating safe and non-invasive treatments for cancer,
diabetes, asthma, Alzheimer's, cardiovascular disease and a host of other
conditions.

Presenters will examine Intracellular and Gene Drug Delivery, the Delivery of
Biologicals, the Pharmacology of Drug Delivery and Recent Clinical Activities. Peter
Hoffman, Vice President of New Technology Development for Genzyme Corporation will
deliver the keynote address entitled, "American Revolution in CNS Therapy: CNS Drug
Delivery". Hoffman will be joined at this conference by presenters from
Bristol-Myers Squibb, Novartis Vaccines, 3M HealthCare Ltd, Genzyme, Merck, Serono
and other leading research organizations.

Drug Delivery Technology is a part of the 2nd Modern Drug Discovery & Development
Summit (M3D 2006). The Summit will take place December 4-6, 2006 at the
Pennsylvania Convention Center. Over 250 speakers will participate in 11 concurrent
conferences. For more information, visit www.gtcbio.com


Web Site = http://www.gtcbio.com

Contact Details = ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.
For more information contact Christy Bowman at GTCbio. Phone: (626) 256-6405 x101,
Fax: (626) 256-6460, Email: Christy.bowman@gtcbio.com